CEACAM7
protein-codingCEA cell adhesion molecule 7, the group of V-set domain containing|CEA cell adhesion molecule family
Gene summary
This gene encodes a cell surface glycoprotein and member of the carcinoembryonic antigen (CEA) family of proteins. Expression of this gene may be downregulated in colon and rectal cancer. Additionally, lower expression levels of this gene may be predictive of rectal cancer recurrence. This gene is present in a CEA family gene cluster on chromosome 19. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
- CGM2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~33.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CEACAM7 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001291485.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 2 | |||
| missense | 42 | 2 | 44 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 43 | 3 | 0 | 46 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001278414.1 | 4 | MANE Select | |
| Ensembl | ENSP00000385932.1 | 4 | MANE Select | |
| RefSeq | NP_008821.2 | 4 | Standard | |
| Ensembl | ENSP00000006724.3 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Post-translational modification: synthesis of GPI-anchored proteins
- Post-translational protein modification
- Metabolism of proteins
Cellular Component
- extracellular region
- plasma membrane
- apical plasma membrane
- anchored component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000006724
- Coding exons
- 4
- Length
- 33661
- Individuals with no LoFs
- 125138
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 602
- Defined
- 125741
- p
- 0.00240
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.637 | 172 | 150 | 1.15 | 0.00000811 | 1711 |
| Missense (PolyPhen) | 57 | 44.305 | 1.2865 | 577 | ||
| Synonymous | -0.192 | 64 | 62.1 | 1.03 | 0.00000372 | 538 |
| Loss of Function | 0.227 | 11 | 11.8 | 0.929 | 6.36e-7 | 125 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00056 | 0.00055 | rare |
| Latino/Admixed American | 0.00074 | 0.00072 | rare |
| Ashkenazi Jewish | 0.0066 | 0.0066 | notable |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.00037 | 0.00037 | rare |
| European (Non-Finnish) | 0.0035 | 0.0035 | notable |
| South Asian | 0.0027 | 0.0027 | notable |
| Other | 0.0023 | 0.0023 | notable |
dbNSFP Gene Annotations
Source:
Intolerance Scores
- LoFtool
- 0.849
- RVIS EVS
- 0.97
- RVIS percentile EVS
- 90.34
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0997
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |